These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10529784)

  • 1. Duchenne muscular dystrophy improved by gentamicin.
    Senior K
    Mol Med Today; 1999 Nov; 5(11):461. PubMed ID: 10529784
    [No Abstract]   [Full Text] [Related]  

  • 2. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.
    Arakawa M; Shiozuka M; Nakayama Y; Hara T; Hamada M; Kondo S; Ikeda D; Takahashi Y; Sawa R; Nonomura Y; Sheykholeslami K; Kondo K; Kaga K; Kitamura T; Suzuki-Miyagoe Y; Takeda S; Matsuda R
    J Biochem; 2003 Nov; 134(5):751-8. PubMed ID: 14688241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When running a stop sign may be a good thing.
    Karpati G; Lochmuller H
    Ann Neurol; 2001 Jun; 49(6):693-4. PubMed ID: 11409418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Duchenne muscular dystrophy with gentamicin].
    Matsuo M; Takeshima Y; Yagi M; Ishibashi K; Wada H
    No To Hattatsu; 2004 Mar; 36(2):125-9. PubMed ID: 15031986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.
    Wagner KR; Hamed S; Hadley DW; Gropman AL; Burstein AH; Escolar DM; Hoffman EP; Fischbeck KH
    Ann Neurol; 2001 Jun; 49(6):706-11. PubMed ID: 11409421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
    Barton-Davis ER; Cordier L; Shoturma DI; Leland SE; Sweeney HL
    J Clin Invest; 1999 Aug; 104(4):375-81. PubMed ID: 10449429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy: from gene to patient.
    Hopkins JC; Bia BL; Crilley JG; Boehm EA; Sang AE; Tinsley JM; King LM; Radda GK; Davies KE; Clarke K
    MAGMA; 2000 Nov; 11(1-2):7-9. PubMed ID: 11186993
    [No Abstract]   [Full Text] [Related]  

  • 11. Duchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?
    Rafael-Fortney JA; Chadwick JA; Raman SV
    Circ Res; 2016 Apr; 118(7):1059-61. PubMed ID: 27034274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
    Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
    Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
    Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
    Dunckley MG; Eperon IC; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
    Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
    Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy of corticosteroid and gentamicin for Duchenne muscular dystrophy--a basic study].
    Kondo E; Kawamichi Y; Sagara Y; Saito K
    No To Hattatsu; 2009 Mar; 41(2):132-4. PubMed ID: 19517780
    [No Abstract]   [Full Text] [Related]  

  • 19. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Readthrough strategies for stop codons in Duchenne muscular dystrophy.
    Aurino S; Nigro V
    Acta Myol; 2006 Jun; 25(1):5-12. PubMed ID: 17039975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.